Stephen Mason
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Stephen Mason has a total of 271 co-authors. Here are the top co-authors by number of shared publications:
- Anderson Takeo Hara
Department of Biomedical and Applied Sciences, Oral Health Research Institute, Indiana University School of Dentistry, 415 N Lansing St, Indianapolis, IN 46202, USA
5 shared publications Brenda Maggio
GlaxoSmithKline Consumer Healthcare, Parsippany, NJ 07054, USA
5 shared publications- Charles Richard Parkinson
Haleon Weybridge Surrey UK
5 shared publications - Farzana Sufi
GSK Consumer Healthcare, Weybridge, Surrey, UK
5 shared publications Nathan Hughes
5 shared publicationsPeter Jeffery
5 shared publications
Latest Publications
- Open Access
- 12 December 2025
- Published by Elsevier in International Dental Journal
- Vol. 76 (1) , 109320
Exploring Patient-Reported Gingival Health in Adults Using Standardised International FDI Oral Health Observatory Data
- 12 December 2025
- Published by Elsevier in International Dental Journal
- Vol. 76 (1) , 109320
Open AccessExploring Patient-Reported Gingival Health in Adults Using Standardised International FDI Oral Health Observatory Data
- Open Access
- 1 March 2025
- Published by National Institute for Health and Care Research in Public Health Research
- p. 1-13
Developing research collaborations and building capacity in palliative and end-of-life care in the North West Coast of England: the PalCaRe-NWC partnership
Background: The North West Coast area of England (Lancashire, Merseyside, Cheshire and South Cumbria) has high palliative care need (third highest prevalence in England) and historically low recorded National Institute for Health and Care Research research activity (second lowest research recruitment rate in England). To stimulate research activity, a new research partnership was formed to support and encourage palliative care research, funded by the National Institute for Health and Care Research from January 2022 until June 2023. Objectives: To develop a sustainable palliative care research partnership infrastructure across the North West Coast. To work with palliative care providers, patients and the public, and research staff to further understand local barriers and facilitators to palliative and end-of-life care research, and develop and implement solutions to these barriers. To build capacity in palliative and end-of-life care research through the mentorship of emerging research leaders and share expertise across organisations. To facilitate the development of high-quality research grant applications. Activities: Phased activities were planned and actioned throughout the funded period to develop and embed an active palliative care research partnership across the region. These included: a survey and working groups to rapidly identify current local barriers to research and their sustainable solutions; individual and group support activities to build research capabilities and capacity; development and submission of high-quality, clinically relevant research proposals to the National Institute for Health and Care Research and other funders. Results: Survey participants (n = 293) were mainly from clinical settings (71%), with 45% being nurses. While around three-quarters of participants were not research active, most wanted to increase their involvement. Key barriers identified from both the survey and working groups (n = 20 professional participants) included: lack of organisational research culture and capacity (including prioritisation and available time); research knowledge (including skills/expertise and funding opportunities); research infrastructure (including collaborative opportunities across multiple organisations and governance challenges); and patient and public perceptions of research (including vulnerabilities and burdens). Based on these findings, the partnership is working with national stakeholders to develop user-friendly resources to facilitate hospice-based research. Three action learning sets, that met several times (n = 15 staff), and two networking events (n = 78 participants) took place to facilitate collaboration and research capacity building. Eleven research grant applications totalling £5,435,967 were submitted as a direct result of partnership activities between January 2022 and June 2023. Limitations: Survey and working group findings and resulting activities represent the views and needs of staff within a particular United Kingdom geography and had limited public representation. Conclusions: Funding to support partnership work has been demonstrated to be effective in pump-priming research activities, leading to successful research grant submissions and building research capacity. However, consideration is needed about how to maintain partnership work, embed in local organisations and further develop work across non-traditional stakeholders such as hospices and social care providers if ongoing funding is unavailable. Future work: North West Coast Clinical Research Network has provided short-term funding (July 2023–March 2024) to enable and sustain the expansion of Palliative Care Research Partnership North West Coast. Funding: This article presents independent research funded by the National Institute for Health and Care Research (NIHR) Public Health Research programme as award number NIHR135334.
- 1 March 2025
- Published by National Institute for Health and Care Research in Public Health Research
- p. 1-13
Open AccessDeveloping research collaborations and building capacity in palliative and end-of-life care in the North West Coast of England: the PalCaRe-NWC partnership
Background: The North West Coast area of England (Lancashire, Merseyside, Cheshire and South Cumbria) has high palliative care need (third highest prevalence in England) and historically low recorded National Institute for Health and Care Research research activity (second lowest research recruitment rate in England). To stimulate research activity, a new research partnership was formed to support and encourage palliative care research, funded by the National Institute for Health and Care Research from January 2022 until June 2023. Objectives: To develop a sustainable palliative care research partnership infrastructure across the North West Coast. To work with palliative care providers, patients and the public, and research staff to further understand local barriers and facilitators to palliative and end-of-life care research, and develop and implement solutions to these barriers. To build capacity in palliative and end-of-life care research through the mentorship of emerging research leaders and share expertise across organisations. To facilitate the development of high-quality research grant applications. Activities: Phased activities were planned and actioned throughout the funded period to develop and embed an active palliative care research partnership across the region. These included: a survey and working groups to rapidly identify current local barriers to research and their sustainable solutions; individual and group support activities to build research capabilities and capacity; development and submission of high-quality, clinically relevant research proposals to the National Institute for Health and Care Research and other funders. Results: Survey participants (n = 293) were mainly from clinical settings (71%), with 45% being nurses. While around three-quarters of participants were not research active, most wanted to increase their involvement. Key barriers identified from both the survey and working groups (n = 20 professional participants) included: lack of organisational research culture and capacity (including prioritisation and available time); research knowledge (including skills/expertise and funding opportunities); research infrastructure (including collaborative opportunities across multiple organisations and governance challenges); and patient and public perceptions of research (including vulnerabilities and burdens). Based on these findings, the partnership is working with national stakeholders to develop user-friendly resources to facilitate hospice-based research. Three action learning sets, that met several times (n = 15 staff), and two networking events (n = 78 participants) took place to facilitate collaboration and research capacity building. Eleven research grant applications totalling £5,435,967 were submitted as a direct result of partnership activities between January 2022 and June 2023. Limitations: Survey and working group findings and resulting activities represent the views and needs of staff within a particular United Kingdom geography and had limited public representation. Conclusions: Funding to support partnership work has been demonstrated to be effective in pump-priming research activities, leading to successful research grant submissions and building research capacity. However, consideration is needed about how to maintain partnership work, embed in local organisations and further develop work across non-traditional stakeholders such as hospices and social care providers if ongoing funding is unavailable. Future work: North West Coast Clinical Research Network has provided short-term funding (July 2023–March 2024) to enable and sustain the expansion of Palliative Care Research Partnership North West Coast. Funding: This article presents independent research funded by the National Institute for Health and Care Research (NIHR) Public Health Research programme as award number NIHR135334.
- Open Access
- 2 February 2024
- Published by Elsevier in International Dental Journal
- Vol. 74 (3) , 647-655
Using Standardised International Oral Health-Related Datasets in 6 Countries
- 2 February 2024
- Published by Elsevier in International Dental Journal
- Vol. 74 (3) , 647-655
Open AccessUsing Standardised International Oral Health-Related Datasets in 6 Countries
- Open Access
- 14 March 2023
- Published by Elsevier in International Dental Journal
- Vol. 73 (4) , 566-573
Standardised Practice-Based Oral Health Data Collection: A Pilot Study in Different Countries
- 14 March 2023
- Published by Elsevier in International Dental Journal
- Vol. 73 (4) , 566-573
Open AccessStandardised Practice-Based Oral Health Data Collection: A Pilot Study in Different Countries
- Open Access
- 1 February 2022
- Published by Elsevier in The Journal of Prosthetic Dentistry
- Vol. 127 (2) , 266.e1-266.e7
Development of a United Kingdom–centric cost-effectiveness model for denture cleaning strategies
- 1 February 2022
- Published by Elsevier in The Journal of Prosthetic Dentistry
- Vol. 127 (2) , 266.e1-266.e7
Open AccessDevelopment of a United Kingdom–centric cost-effectiveness model for denture cleaning strategies
- Open Access
- 1 January 2021
- Vol. 19 (1) , 609-618
A Randomised Clinical Study to Evaluate Efficacy on Gingival Health of 62% and 67% Sodium Bicarbonate Toothpastes
Purpose: This randomised, examiner-blind, parallel study compared gingival bleeding and plaque control following 12 weeks' twice-daily use of 67%, 62% or 0% sodium bicarbonate (NaHCO3)-containing toothpastes. Materials and Methods: Adults with mild-to-moderate gingivitis, >= 20 gingival bleeding sites and bleeding after brushing were randomised to toothpastes containing 923 ppm sodium fluoride and either 67% NaHCO3, 62% NaHCO3 + 5% w/w silica, or 0% NaHCO3. Gingival bleeding was assessed with the Saxton and van der Ouderaa Bleeding Index (BI), plaque was assessed with the Turesky modification of the Quigley-Hein Plaque Index (TPI). Results: There were significantly fewer bleeding sites at Week 12 (primary endpoint) for 67% NaHCO3 (n = 110) and 62% NaHCO3 (n = 110) groups compared with the 0% NaHCO3 group (n = 110) (treatment differences: -3.1 [97.5% confidence interval (CI) -5.5, -0.7] P = 0.0068 and -2.4 [-4.8, 0.0] P = 0.0448, respectively). Statistically significant differences were also seen at Week 6 (P = 0.0361 for 67% NaHCO3, P = 0.0044 for 62% NaHCO3 compared to 0% NaHCO3). Compared with the 0% NaHCO3 group, BI was significantly lower in the 67% NaHCO3 group at Weeks 6 and 12 (P = 0.0477 and P = 0.0066, respectively). TPI was significantly lower in the 67% NaHCO3 and 62% NaHCO3 groups at Week 6 (P = 0.0336 and 0.0009, respectively) but not at Week 12. No statistically significant differences were found between the 67% NaHCO3 and 62% NaHCO3 toothpastes for any variable. No treatment-related adverse events were reported. Conclusion: Twice-daily brushing over 12 weeks with toothpastes containing 67% NaHCO3 or 62% NaHCO3 significantly improved plaque control and reduced indices of bleeding in participants with mild-to-moderate gingivitis.
- 1 January 2021
- Vol. 19 (1) , 609-618
Open AccessA Randomised Clinical Study to Evaluate Efficacy on Gingival Health of 62% and 67% Sodium Bicarbonate Toothpastes
Purpose: This randomised, examiner-blind, parallel study compared gingival bleeding and plaque control following 12 weeks' twice-daily use of 67%, 62% or 0% sodium bicarbonate (NaHCO3)-containing toothpastes. Materials and Methods: Adults with mild-to-moderate gingivitis, >= 20 gingival bleeding sites and bleeding after brushing were randomised to toothpastes containing 923 ppm sodium fluoride and either 67% NaHCO3, 62% NaHCO3 + 5% w/w silica, or 0% NaHCO3. Gingival bleeding was assessed with the Saxton and van der Ouderaa Bleeding Index (BI), plaque was assessed with the Turesky modification of the Quigley-Hein Plaque Index (TPI). Results: There were significantly fewer bleeding sites at Week 12 (primary endpoint) for 67% NaHCO3 (n = 110) and 62% NaHCO3 (n = 110) groups compared with the 0% NaHCO3 group (n = 110) (treatment differences: -3.1 [97.5% confidence interval (CI) -5.5, -0.7] P = 0.0068 and -2.4 [-4.8, 0.0] P = 0.0448, respectively). Statistically significant differences were also seen at Week 6 (P = 0.0361 for 67% NaHCO3, P = 0.0044 for 62% NaHCO3 compared to 0% NaHCO3). Compared with the 0% NaHCO3 group, BI was significantly lower in the 67% NaHCO3 group at Weeks 6 and 12 (P = 0.0477 and P = 0.0066, respectively). TPI was significantly lower in the 67% NaHCO3 and 62% NaHCO3 groups at Week 6 (P = 0.0336 and 0.0009, respectively) but not at Week 12. No statistically significant differences were found between the 67% NaHCO3 and 62% NaHCO3 toothpastes for any variable. No treatment-related adverse events were reported. Conclusion: Twice-daily brushing over 12 weeks with toothpastes containing 67% NaHCO3 or 62% NaHCO3 significantly improved plaque control and reduced indices of bleeding in participants with mild-to-moderate gingivitis.
- Open Access
- 29 September 2020
- Published by Royal Society of Chemistry (RSC)
- p. 75-108
Oral Care – A Mouthful of Chemistry
Hard enamel on the outside of teeth is supported by softer underlying dentine and pulp. Enamel is mostly composed of hydroxyapatite, formed from calcium and phosphate. Enamel can be weakened if the oral environment becomes too acidic (pH<5.5), but hydroxyapatite can be re-formed from salivary minerals. However, if this environment is too acidic for too long, enamel can be permanently lost, leading to tooth erosion and/or dentine hypersensitivity. Teeth, and gums, can also be affected by oral bacteria, especially in the form of plaque, which can lead to caries and gum disease, and by deposits of calculus. Fluoride toothpaste, delivered via a suitable toothbrush and brushing technique, can help with enamel remineralization and limit bacterial growth. Abrasives in toothpaste, along with chemical agents, can remove dental plaque and stained pellicle, the layer that forms over enamel. Additional ingredients, alongside different fluoride preparations, include those that can help with dentine hypersensitivity or gum disease, can limit calculus build-up or can whiten teeth. Formulation considerations must balance all of these ingredients and pack them in a toothpaste that not only works, with any product benefit claims being substantiated, but also tastes and feels good to use twice per day, every day.
- 29 September 2020
- Published by Royal Society of Chemistry (RSC)
- p. 75-108
Open AccessOral Care – A Mouthful of Chemistry
Hard enamel on the outside of teeth is supported by softer underlying dentine and pulp. Enamel is mostly composed of hydroxyapatite, formed from calcium and phosphate. Enamel can be weakened if the oral environment becomes too acidic (pH<5.5), but hydroxyapatite can be re-formed from salivary minerals. However, if this environment is too acidic for too long, enamel can be permanently lost, leading to tooth erosion and/or dentine hypersensitivity. Teeth, and gums, can also be affected by oral bacteria, especially in the form of plaque, which can lead to caries and gum disease, and by deposits of calculus. Fluoride toothpaste, delivered via a suitable toothbrush and brushing technique, can help with enamel remineralization and limit bacterial growth. Abrasives in toothpaste, along with chemical agents, can remove dental plaque and stained pellicle, the layer that forms over enamel. Additional ingredients, alongside different fluoride preparations, include those that can help with dentine hypersensitivity or gum disease, can limit calculus build-up or can whiten teeth. Formulation considerations must balance all of these ingredients and pack them in a toothpaste that not only works, with any product benefit claims being substantiated, but also tastes and feels good to use twice per day, every day.
- Open Access
- 22 October 2019
- Published by Springer Nature in BMC Oral Health
- Vol. 19 (1) , 1-11
Impact of toothpaste on oral health-related quality of life in people with dentine hypersensitivity
Background: Dentine hypersensitivity can impact functional status and everyday activities such as eating and talking. This study aimed to assess changes in oral health-related quality of life measures in individuals with dentine hypersensitivity following long-term use (24 weeks) of a commercially available toothpaste marketed for dentine hypersensitivity relief. Methods: This study was conducted across two sites and enrolled 75 adults with ≥2 non-adjacent sensitive teeth. Participants were assigned to twice-daily brushing with toothpaste containing 0.454% w/w stannous fluoride (1100 ppm fluoride). Every 4 weeks, participant-reported outcomes were assessed using the Dentine Hypersensitivity Experience Questionnaire (DHEQ), a condition specific oral health-related quality of life scale that has five domains and includes questions on social and emotional impact, restrictions, adaptations and effect on life overall. Responses to a clinically applied evaporative (air) stimulus were assessed using the examiner-observed Schiff sensitivity scale and Labelled Magnitude Scales (LMS), which included dentine hypersensitivity-specific descriptors of intensity, duration, tolerability and descriptive qualities of the participant’s response. Results: Participant-reported outcomes demonstrated reduction of the impact of dentine hypersensitivity over time on health-related quality of life, as measured by the DHEQ. This reached statistical significance from Week 8 onwards (p < 0.0001 versus baseline) for the Total DHEQ score, with scores continually decreasing at each timepoint. Most domain scores followed a similar pattern. Statistically significant reductions were also detected for the examiner-observed Schiff Sensitivity Scale scores at all timepoints (including at 4 weeks) (p < 0.05), which were mirrored by LMS responses. The toothpaste was generally well-tolerated. Conclusions: These results show that long-term use of a sensitivity toothpaste containing 0.454% w/w stannous fluoride has a beneficial, ongoing, impact on the oral health-related quality of life of people with dentine hypersensitivity. Trial registration: This study was registered at Clinicaltrials.gov (https://clinicaltrials.gov/ct2/show/NCT02752958) on April 27, 2016.
- 22 October 2019
- Published by Springer Nature in BMC Oral Health
- Vol. 19 (1) , 1-11
Open AccessImpact of toothpaste on oral health-related quality of life in people with dentine hypersensitivity
Background: Dentine hypersensitivity can impact functional status and everyday activities such as eating and talking. This study aimed to assess changes in oral health-related quality of life measures in individuals with dentine hypersensitivity following long-term use (24 weeks) of a commercially available toothpaste marketed for dentine hypersensitivity relief. Methods: This study was conducted across two sites and enrolled 75 adults with ≥2 non-adjacent sensitive teeth. Participants were assigned to twice-daily brushing with toothpaste containing 0.454% w/w stannous fluoride (1100 ppm fluoride). Every 4 weeks, participant-reported outcomes were assessed using the Dentine Hypersensitivity Experience Questionnaire (DHEQ), a condition specific oral health-related quality of life scale that has five domains and includes questions on social and emotional impact, restrictions, adaptations and effect on life overall. Responses to a clinically applied evaporative (air) stimulus were assessed using the examiner-observed Schiff sensitivity scale and Labelled Magnitude Scales (LMS), which included dentine hypersensitivity-specific descriptors of intensity, duration, tolerability and descriptive qualities of the participant’s response. Results: Participant-reported outcomes demonstrated reduction of the impact of dentine hypersensitivity over time on health-related quality of life, as measured by the DHEQ. This reached statistical significance from Week 8 onwards (p < 0.0001 versus baseline) for the Total DHEQ score, with scores continually decreasing at each timepoint. Most domain scores followed a similar pattern. Statistically significant reductions were also detected for the examiner-observed Schiff Sensitivity Scale scores at all timepoints (including at 4 weeks) (p < 0.05), which were mirrored by LMS responses. The toothpaste was generally well-tolerated. Conclusions: These results show that long-term use of a sensitivity toothpaste containing 0.454% w/w stannous fluoride has a beneficial, ongoing, impact on the oral health-related quality of life of people with dentine hypersensitivity. Trial registration: This study was registered at Clinicaltrials.gov (https://clinicaltrials.gov/ct2/show/NCT02752958) on April 27, 2016.
- Open Access
- 1 October 2019
- Published by Springer Nature in Research Square
Impact of toothpaste on oral health-related quality of life in people with dentine hypersensitivity
Background: Dentine hypersensitivity can impact functional status and everyday activities such as eating and talking. This study aimed to assess changes in oral health-related quality of life measures in individuals with dentine hypersensitivity following long-term use (24 weeks) of a commercially available toothpaste marketed for dentine hypersensitivity relief. Methods: This study was conducted across two sites and enrolled 75 adults with ≥2 non-adjacent sensitive teeth. Participants were assigned to twice-daily brushing with toothpaste containing 0.454% w/w stannous fluoride (1100 ppm fluoride). Every 4 weeks, participant-reported outcomes were assessed using the Dentine Hypersensitivity Experience Questionnaire (DHEQ), a condition specific oral health-related quality of life scale that has five domains and includes questions on social and emotional impact, restrictions, adaptations and effect on life overall. Responses to a clinically applied evaporative (air) stimulus were assessed using the examiner-observed Schiff sensitivity scale and Labelled Magnitude Scales (LMS), which included dentine hypersensitivity-specific descriptors of intensity, duration, tolerability and descriptive qualities of the participant’s response. Results: Participant-reported outcomes demonstrated reduction of the impact of dentine hypersensitivity over time on health-related quality of life, as measured by the DHEQ. This reached statistical significance from Week 8 onwards (p<0.0001 versus baseline) for the Total DHEQ score, with scores continually decreasing at each timepoint. Most domain scores followed a similar pattern. Statistically significant reductions were also detected for the examiner-observed Schiff Sensitivity Scale scores at all timepoints (including at 4 weeks) (p<0.05), which were mirrored by LMS responses. The toothpaste was generally well-tolerated. Conclusions: These results show that long-term use of a sensitivity toothpaste containing 0.454% w/w stannous fluoride has a beneficial, ongoing, impact on the oral health-related quality of life of people with dentine hypersensitivity.
- 1 October 2019
- Published by Springer Nature in Research Square
Open AccessImpact of toothpaste on oral health-related quality of life in people with dentine hypersensitivity
Background: Dentine hypersensitivity can impact functional status and everyday activities such as eating and talking. This study aimed to assess changes in oral health-related quality of life measures in individuals with dentine hypersensitivity following long-term use (24 weeks) of a commercially available toothpaste marketed for dentine hypersensitivity relief. Methods: This study was conducted across two sites and enrolled 75 adults with ≥2 non-adjacent sensitive teeth. Participants were assigned to twice-daily brushing with toothpaste containing 0.454% w/w stannous fluoride (1100 ppm fluoride). Every 4 weeks, participant-reported outcomes were assessed using the Dentine Hypersensitivity Experience Questionnaire (DHEQ), a condition specific oral health-related quality of life scale that has five domains and includes questions on social and emotional impact, restrictions, adaptations and effect on life overall. Responses to a clinically applied evaporative (air) stimulus were assessed using the examiner-observed Schiff sensitivity scale and Labelled Magnitude Scales (LMS), which included dentine hypersensitivity-specific descriptors of intensity, duration, tolerability and descriptive qualities of the participant’s response. Results: Participant-reported outcomes demonstrated reduction of the impact of dentine hypersensitivity over time on health-related quality of life, as measured by the DHEQ. This reached statistical significance from Week 8 onwards (p<0.0001 versus baseline) for the Total DHEQ score, with scores continually decreasing at each timepoint. Most domain scores followed a similar pattern. Statistically significant reductions were also detected for the examiner-observed Schiff Sensitivity Scale scores at all timepoints (including at 4 weeks) (p<0.05), which were mirrored by LMS responses. The toothpaste was generally well-tolerated. Conclusions: These results show that long-term use of a sensitivity toothpaste containing 0.454% w/w stannous fluoride has a beneficial, ongoing, impact on the oral health-related quality of life of people with dentine hypersensitivity.
- Open Access
- 1 October 2019
- Published by Springer Nature in Research Square
Impact of toothpaste on oral health-related quality of life in people with dentine hypersensitivity
Background: Dentine hypersensitivity can impact functional status and everyday activities such as eating and talking. This study aimed to assess changes in oral health-related quality of life measures in individuals with dentine hypersensitivity following long-term use (24 weeks) of a commercially available toothpaste marketed for dentine hypersensitivity relief. Methods: This study was conducted across two sites and enrolled 75 adults with ≥2 non-adjacent sensitive teeth. Participants were assigned to twice-daily brushing with toothpaste containing 0.454% w/w stannous fluoride (1100 ppm fluoride). Every 4 weeks, participant-reported outcomes were assessed using the Dentine Hypersensitivity Experience Questionnaire (DHEQ), a condition specific oral health-related quality of life scale that has five domains and includes questions on social and emotional impact, restrictions, adaptations and effect on life overall. Responses to a clinically applied evaporative (air) stimulus were assessed using the examiner-observed Schiff sensitivity scale and Labelled Magnitude Scales (LMS), which included dentine hypersensitivity-specific descriptors of intensity, duration, tolerability and descriptive qualities of the participant’s response. Results: Participant-reported outcomes demonstrated reduction of the impact of dentine hypersensitivity over time on health-related quality of life, as measured by the DHEQ. This reached statistical significance from Week 8 onwards (p<0.0001 versus baseline) for the Total DHEQ score, with scores continually decreasing at each timepoint. Most domain scores followed a similar pattern. Statistically significant reductions were also detected for the examiner-observed Schiff Sensitivity Scale scores at all timepoints (including at 4 weeks) (p<0.05), which were mirrored by LMS responses. The toothpaste was generally well-tolerated. Conclusions: These results show that long-term use of a sensitivity toothpaste containing 0.454% w/w stannous fluoride has a beneficial, ongoing, impact on the oral health-related quality of life of people with dentine hypersensitivity.
- 1 October 2019
- Published by Springer Nature in Research Square
Open AccessImpact of toothpaste on oral health-related quality of life in people with dentine hypersensitivity
Background: Dentine hypersensitivity can impact functional status and everyday activities such as eating and talking. This study aimed to assess changes in oral health-related quality of life measures in individuals with dentine hypersensitivity following long-term use (24 weeks) of a commercially available toothpaste marketed for dentine hypersensitivity relief. Methods: This study was conducted across two sites and enrolled 75 adults with ≥2 non-adjacent sensitive teeth. Participants were assigned to twice-daily brushing with toothpaste containing 0.454% w/w stannous fluoride (1100 ppm fluoride). Every 4 weeks, participant-reported outcomes were assessed using the Dentine Hypersensitivity Experience Questionnaire (DHEQ), a condition specific oral health-related quality of life scale that has five domains and includes questions on social and emotional impact, restrictions, adaptations and effect on life overall. Responses to a clinically applied evaporative (air) stimulus were assessed using the examiner-observed Schiff sensitivity scale and Labelled Magnitude Scales (LMS), which included dentine hypersensitivity-specific descriptors of intensity, duration, tolerability and descriptive qualities of the participant’s response. Results: Participant-reported outcomes demonstrated reduction of the impact of dentine hypersensitivity over time on health-related quality of life, as measured by the DHEQ. This reached statistical significance from Week 8 onwards (p<0.0001 versus baseline) for the Total DHEQ score, with scores continually decreasing at each timepoint. Most domain scores followed a similar pattern. Statistically significant reductions were also detected for the examiner-observed Schiff Sensitivity Scale scores at all timepoints (including at 4 weeks) (p<0.05), which were mirrored by LMS responses. The toothpaste was generally well-tolerated. Conclusions: These results show that long-term use of a sensitivity toothpaste containing 0.454% w/w stannous fluoride has a beneficial, ongoing, impact on the oral health-related quality of life of people with dentine hypersensitivity.